nitroglycerin has been researched along with bosentan anhydrous in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Borthayre, AB; Harrison, DG; Hink, U; Kurz, S; Münzel, T; Nickenig, G | 1 |
| Chen, Y; Tang, T; Wang, X; Zhang, J | 1 |
| Abd-Elsalam, MA | 1 |
| Bahde, R; Bandi, S; Bhargava, KK; Gupta, S; Kapoor, S; Palestro, CJ | 1 |
| Baba, T; Iijima, S; Ohishi, A; Ueno, D | 1 |
2 review(s) available for nitroglycerin and bosentan anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hypertrophic pyloric stenosis following persistent pulmonary hypertension of the newborn: a case report and literature review.
Topics: Antihypertensive Agents; Atropine; Bosentan; Bronchodilator Agents; Female; High-Frequency Ventilation; Humans; Infant, Newborn; Meconium Aspiration Syndrome; Muscarinic Antagonists; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Persistent Fetal Circulation Syndrome; Pyloric Stenosis, Hypertrophic; Sildenafil Citrate; Vasodilator Agents | 2018 |
5 other study(ies) available for nitroglycerin and bosentan anhydrous
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Evidence for a causal role of the renin-angiotensin system in nitrate tolerance.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Drug Tolerance; Endothelium, Vascular; Female; Gene Expression; Losartan; Luminescent Measurements; Male; Multienzyme Complexes; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitrates; Nitric Oxide; Nitroglycerin; Peptidyl-Dipeptidase A; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Sulfonamides; Superoxides; Vasoconstriction; Vasodilation; Vasodilator Agents | 1999 |
Effect of angiotensin II receptor antagonist and endothelin receptor antagonist on nitroglycerin tolerance in rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Bosentan; Drug Tolerance; Endothelin Receptor Antagonists; Losartan; Male; Nitroglycerin; Rats; Rats, Wistar; Sulfonamides; Vasodilator Agents | 2001 |
Bosentan, a selective and more potent antagonist for Atractaspis envenomation than the specific antivenom.
Topics: Animals; Antivenins; Bosentan; Electrocardiography; Endothelin Receptor Antagonists; Heart; Humans; Male; Nitroglycerin; Rabbits; Snake Bites; Snakes; Sulfonamides | 2011 |
Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver.
Topics: Animals; Bosentan; Cardiovascular Agents; Dipeptidyl Peptidase 4; Endothelin Receptor Antagonists; Epoprostenol; Hepatocytes; Lisinopril; Liver; Losartan; Nitroglycerin; Rats; Rats, Inbred F344; Sulfonamides | 2013 |